PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 313,500
+4,000 (1.29%)
Mar 27, 2026, 3:19 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 3.22 trillion as of March 26, 2026. Its market cap has increased by 2.82% in one year.
Market Cap
3.22T
Enterprise Value
2.85T
Revenue
536.29B
Ranking
n/a
PE Ratio
20.73
Stock Price
313,500.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 3.22T, an increase of 218.61%. That is a compound annual growth rate of 11.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 3.22T | -23.20% |
| Dec 30, 2025 | 4.19T | 53.52% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LigaChem Biosciences | 7.77T |
| Peptron | 7.62T |
| SK Biopharmaceuticals | 7.61T |
| HLB Co., Ltd. | 6.64T |
| Voronoi | 5.51T |
| OliX Pharmaceuticals | 3.79T |
| SK bioscience | 3.36T |
| D&D Pharmatech | 3.21T |